The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $569.5 million definitive contract to Roche Diagnostics Corporation. The contract is for COVID-19 antigen test kits to support the Department of Defense and Department of Health and Human Services in response to the coronavirus pandemic. The original solicitation sought information on the availability of over-the-counter COVID-19 rapid antigen tests that could be used by government personnel, including details on production capacity, manufacturing locations, inventory levels, packaging configurations, and monthly production capabilities through April 2022. The place of performance for Roche Diagnostics Corporation is in Castleton, Indiana. The contract has a period of performance from January 13, 2022 through May 31, 2022 and utilizes a firm fixed price contract type.
Generated 12/29/23, 5:06 PM